Molecular Partners, a clinical-stage biotech company specializing in DARPin therapeutics for cancer, announced it will present its latest developments and outlook at the inaugural UBS Global Biopharma Conference in London on November 17, 2026. The presentation by CEO Patrick Amstutz will highlight progress in their targeted radiotherapeutics, including the lead drug MP0712 in Phase 1/2a trials for small cell lung cancer. This event offers investors insight into Molecular Partners' innovative cancer treatments and future plans.
Molecular Partners' latest developments come as the health sector on Pluang shows a breadth of 46 advancing and 100 declining stocks out of 150 priced US health stocks. For readers following health stocks, here is Pluang's market snapshot as of Nov 13, 2026 13:11 WIB: Erasca Inc. (ERAS) traded at USD 15.73 with a 1-day change of -6.37% and a typical hold time of 4 days; ClearPoint Neuro Inc. (CLPT) was priced at USD 8.61, down 6.11%, with 100% sell order activity and a typical hold time of 13 days; Butterfly Network Inc. (BFLY) stood at USD 6.71, down 6.02%, with a typical hold time of 17 days.
The 9th Shandong-South Korea Economic and Trade Cooperation Conference and Yantai South Korea Week began on November 6 in Yantai, Shandong Province, highlighting strong economic ties between Shandong and South Korea. Over 150 enterprises participated...
4D Molecular Therapeutics reported a wider adjusted loss of $1.08 per share for Q3 2026, missing analyst expectations. However, the company's revenue reached $4.15 million, surpassing both estimates and last year's figures, continuing a trend of stro...
Kaldvik AS reported a Q3 2026 operating income of EUR 26.1 million, up from EUR 9.9 million the previous year, despite an operating loss before adjustments of EUR -3.8 million. The company harvested 4,483 tonnes in Q3, significantly higher than 1,545...
Following the U.S. midterm elections on November 3, several crypto tokens tied to privacy and perpetual decentralized exchanges experienced significant declines. The TRUMP meme coin dropped nearly 45% over 30 days, with a sharp 17.64% fall in 24 hour...
As of September 30, JPMorgan held approximately $549 million in spot Bitcoin exchange-traded funds, including shares in BlackRock’s iShares Bitcoin Trust and other Bitcoin funds. The bank also increased its investment in MicroStrategy by 36% during t...
